Blog | HemaCare

HPV-Pulsed Dendritic-Cell Vaccination in a Patient with Metastatic Cervical Cancer

Mar 1, 2017 9:29:35 AM / by Stacy Matthews Branch, DVM, PhD posted in bioresearch, Dendritic cells, HPV Vaccination

0 Comments

The diagnosis and treatment of inoperable cervical carcinoma severely affects the quality of life of patients and their caregivers. The one-year survival rate remains under 15%. Dendritic cells have been studied as adjuvants that modify the effects of tumor immunotherapy in humans. A case report has been published that describes the vaccination with dendritic cells of a patient with metastatic cervical cancer.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts